Due in part to the American Society of Clinical Oncology’s big cancer conference, June is often a popular month for M&A activity in the biotech space – and with biotech stocks having fallen over the last couple of months, big pharma firms could be especially busy this June acquiring targets at the current low prices. For a number of possible acquisition targets, CLICK HERE.
Why Biotech M&A Activity Could Heat Up In June – And Some Potential Acquisition Targets
- by RobH
![](https://www.hotstockanalyst.com/wp-content/uploads/2021/05/2021-05-27-08_21_44-text-photo-–-Free-Grey-Image-on-Unsplash.png)
Tags:Acquisition TargetsBiotech M&ABiotech SpaceFallen Biotech StocksInvestInvestingInvestorJune BiotechsLow PricesM&APharma FirmsStock Market